Related Experiment Video
Updated: Jun 25, 2026

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
A Novel BoHV-1-Vectored Subunit RVFV Vaccine Induces a Robust Humoral and Cell-Mediated Immune Response Against Rift
Selvaraj Pavulraj1, Rhett W Stout1, Shafiqul I Chowdhury1
1Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.
A new Rift Valley fever virus (RVF) vaccine using a modified bovine herpesvirus vector shows promise for sheep. This safe and effective subunit vaccine induces strong immune responses, protecting sheep from RVF.
Area of Science:
- Veterinary Virology
- Immunology
- Vaccine Development
Background:
- Rift Valley fever (RVF) is a zoonotic disease impacting livestock and humans, with no approved human vaccines.
- Developing animal vaccines is critical for disease control and preventing human transmission.
- Current research focuses on safe and effective vaccine vectors for livestock.
Purpose of the Study:
- To repurpose a novel bovine herpesvirus type 1 quadruple gene-mutant vector (BoHV-1qmv)-based subunit vaccine for RVF in sheep.
- To evaluate the safety and immunogenicity of this repurposed vaccine in sheep.
Main Methods:
- Engineered a BoHV-1qmv-vectored subunit RVF vaccine (BoHV-1qmv Sub-RVFV) with ovine-codon-optimized sequences and sheep GM-CSF.
- Administered a combined primary intranasal-plus-subcutaneous immunization to sheep.
- Performed an intranasal booster vaccination after 29 days.
- Assessed RVF virus-specific serum-neutralizing (SN) antibodies and cellular immune responses.
Main Results:
- The repurposed vaccine was safe and induced moderate levels of BoHV-1 and RVF virus (MP-12 strain)-specific SN antibodies and cellular immune responses after primary immunization.
- Intranasal booster vaccination rapidly increased MP-12-specific SN antibody titers within 7 days.
- The vaccine demonstrated high immunogenicity in sheep.
Conclusions:
- The BoHV-1qmv-vectored subunit RVF vaccine is a safe and effective candidate for sheep.
- This vaccine holds potential for controlling RVF in sheep populations and preventing zoonotic transmission.
Related Concept Videos
Humoral Immune Responses
Vaccine Production
Rocky Mountain Spotted Fever
Rabies
Arboviral Encephalitis
Respiratory Syncytial Virus Disease

